David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.09% |
| 2 | Technology | 17.04% |
| 3 | Healthcare | 13.44% |
| 4 | Consumer Discretionary | 13.38% |
| 5 | Financials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Bank OZK
OZK
$5.38B
| $2.35M | ﹤0.01% |
81,049
+71,655
| +763% | +$2.17M |
|
2002
CALL
Snap-on
SNA
$20.5B
| $2.35M | ﹤0.01% |
15,000
+10,900
| +266% | +$1.73M |
|
|
PCMI
2003
DELISTED
PCM, Inc
PCMI
| $2.34M | ﹤0.01% |
63,814
+26,872
| +73% | +$748K |
|
2004
PUT
Cboe Global Markets
CBOE
$33.1B
| $2.34M | ﹤0.01% |
24,500
-60,000
| -71% | -$5.69M |
|
2005
CALL
HP
HPQ
$26.2B
| $2.33M | ﹤0.01% |
+120,000
| New | +$2.54M |
|
2006
Reliance Steel & Aluminium
RS
$19.9B
| $2.33M | ﹤0.01% |
25,809
-78,588
| -75% | -$6.55M |
|
|
BEAT
2007
CALL
DELISTED
BioTelemetry, Inc.
BEAT
| $2.33M | ﹤0.01% |
37,200
+18,900
| +103% | +$1.3M |
|
2008
CALL
Welltower
WELL
$172B
| $2.33M | ﹤0.01% |
30,000
+25,000
| +500% | +$1.88M |
|
2009
CALL
Bio-Rad Laboratories Class A
BIO
$10.5B
| $2.32M | ﹤0.01% |
+7,600
| New | +$2.05M |
|
|
BMCH
2010
DELISTED
BMC Stock Holdings, Inc
BMCH
| $2.32M | ﹤0.01% |
131,264
+61,007
| +87% | +$1.06M |
|
2011
PUT
Realty Income
O
$58.6B
| $2.32M | ﹤0.01% |
32,508
+17,544
| +117% | +$1.16M |
|
2012
PUT
Takeda Pharmaceutical
TAK
$57.7B
| $2.32M | ﹤0.01% |
+113,678
| New | +$2.29M |
|
|
AMBR
2013
DELISTED
Amber Road Inc
AMBR
| $2.32M | ﹤0.01% |
267,187
+39,971
| +18% | +$352K |
|
2014
First Bancorp
FBNC
$2.63B
| $2.31M | ﹤0.01% |
66,607
+36,649
| +122% | +$1.34M |
|
2015
Sabesp
SBS
$17B
| $2.31M | ﹤0.01% |
1,125,447
+489,519
| +77% | +$1.02M |
|
2016
Center Bancorp
CNOB
$1.6B
| $2.31M | ﹤0.01% |
117,023
+19,006
| +19% | +$389K |
|
2017
Evercore
EVR
$11.2B
| $2.31M | ﹤0.01% |
25,328
-43,712
| -63% | -$3.84M |
|
2018
CALL
Nucor
NUE
$57B
| $2.31M | ﹤0.01% |
+39,500
| New | +$2.32M |
|
2019
Applied Optoelectronics
AAOI
$9.5B
| $2.3M | ﹤0.01% |
+188,324
| New | +$2.84M |
|
|
VNET
2020
VNET Group
VNET
$1.89B
| $2.3M | ﹤0.01% |
289,339
+243,313
| +529% | +$2.18M |
|
2021
Stanley Black & Decker
SWK
$15B
| $2.3M | ﹤0.01% |
16,859
+3,426
| +26% | +$447K |
|
|
USAK
2022
DELISTED
USA Truck Inc
USAK
| $2.29M | ﹤0.01% |
158,901
-11,371
| -7% | -$193K |
|
2023
PUT
Tyson Foods
TSN
$19.5B
| $2.29M | ﹤0.01% |
33,000
-13,900
| -30% | -$860K |
|
|
WOW
2024
DELISTED
WideOpenWest
WOW
| $2.29M | ﹤0.01% |
251,519
-28,360
| -10% | -$232K |
|
2025
CALL
Campbell Soup
CPB
$6.94B
| $2.29M | ﹤0.01% |
60,000
-50,000
| -45% | -$1.76M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $2.66B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.